0001209191-14-003101.txt : 20140114 0001209191-14-003101.hdr.sgml : 20140114 20140114162505 ACCESSION NUMBER: 0001209191-14-003101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140110 FILED AS OF DATE: 20140114 DATE AS OF CHANGE: 20140114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 28TH STREET STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 2525 28TH STREET STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAST ERLE T CENTRAL INDEX KEY: 0001051411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 14527631 MAIL ADDRESS: STREET 1: C/O SPIROS DEVELOPMENT CORP II INC STREET 2: 7475 LUSK BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-01-10 0 0001466301 Clovis Oncology, Inc. CLVS 0001051411 MAST ERLE T C/O CLOVIS ONCOLOGY, INC. 2525 28TH STREET, SUITE 100 BOULDER CO 80301 0 1 0 0 Executive VP and CFO Stock Option (right to buy) 73.98 2014-01-10 4 A 0 70000 0.00 A 2024-01-10 Common Stock 70000 70000 D The option shall vest as to 25% of the shares on January 10, 2015 and the remainder shall vest in substantially equal installments over the 36 months immediately following such date. /s/ Erle T. Mast 2014-01-13